Mimedx (MDXG) Change in Cash (2011 - 2026)

Mimedx (MDXG) has 16 years of Change in Cash data on file, last reported at -$6.3 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Cash fell 415.04% year-over-year to -$6.3 million; the trailing twelve-month figure through Mar 2026 stood at $53.3 million (down 7.94% YoY), and the FY2025 full-year result was $61.7 million, up 175.27% from the prior year.
• Change in Cash eased to -$6.3 million in Q1 2026, from $24.0 million in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $24.0 million in Q4 2025 to a low of -$33.5 million in Q1 2024.
• A 5-year average of $4.3 million and a median of $2.0 million in 2025 frame the typical range for Change in Cash.
• Across the five-year window, Change in Cash slumped 1316.09% in 2022 and surged 1767.82% in 2024, its largest moves.
• Tracing MDXG's Change in Cash over 5 years: stood at -$7.3 million in 2022, then jumped by 111.5% to $836000.0 in 2023, then surged by 1767.82% to $15.6 million in 2024, then surged by 53.94% to $24.0 million in 2025, then tumbled by 126.41% to -$6.3 million in 2026.
• Business Quant data shows MDXG's Change in Cash at -$6.3 million in Q1 2026, $24.0 million in Q4 2025, and $23.2 million in Q3 2025.